Home / NEWS & DEALS / Deals / details of junhe's deals

JunHe Advised in the Establishment of HighLight Capital RMB Fund III

2019.01.18

Recently, HighLight Capital completed the primary establishment and closing of its 5th Fund (RMB Fund III). The raising amount is approximately 70% of the proposed size of RMB III so far, and the follow-up raising is constantly moving forward. JunHe, as exclusive legal counsel to HighLight Capital, represented and advised HighLight Capital in its establishment of RMB Fund III.


HighLight Capital, as one of the front-line professional investment funds in China, was founded in mid-2014 and focuses on the healthcare industry. Currently, HighLight Capital manage 5 Funds with the amount of over RMB 7 billion, involving USD and RMB currencies. JunHe has been cooperating with HighLight Capital’s team since its inception, and has witnessed their increasingly mature investment wisdom. HighLight Capital are devoted to promoting the healthcare industry, and have successfully invested Mindray Medicail, Yu Yue Medical, WuXi Apptec, Stapharma, Kintor Medical, Pharmaron, Baheal Pharm, Sansure Biotech, Malo Clinic, Rabbit Dental, Chaoju Ophthalmology, Dr.Cuiyutao Healthcare, Chowsing Nourse, and General Healthy etc.


The RMB III Fund is the 5th professional investment fund of HighLight Capital. The project commenced in September 2018, going through initial contact, negotiation、structure design documents drafting、modifying and finalizing with multiple investors, with the project completed in January 2019. The raising amount is approximately 70% of the proposed size of RMB III so far, and the follow-up raising is constantly moving forward. In the big picture of capital winter, HighLight Capital’s raising achievement mirrors that of its historical investment performance and professional management has been recognized by mainstream investors.


JunHe, as exclusive legal counsel to HighLight Capital, provided the following legal services: design of the fund structure, drafting of the whole set of fund documents, and participating in the negotiation and delivery of the project. The RMB III Fund structure is relatively complex, and in the process of designing the fund structure and drafting documents, the JunHe team conducted swift integrations over investors’ needs and coordinated all parties to reach an agreement. The JunHe team advised HighLight Capital in drafting, negotiating and modifying the documents professionally and patiently with their rich experience in USD Funds and RMB Funds. The fund was ultimately established and closed efficiently in set time, and the JunHe team was highly recognized by HighLight Capital.


The lead partners in the Project were Mr. WANG, Yi and Mr. JIANG, Wenjun (Kelvin).


JunHe is the only Chinese law firm to be admitted as a member of Lex Mundi and Multilaw, two international networks of independent law firms. JunHe and selected top law firms in major European and Asian jurisdictions are “best friends.” Through these connections, we provide high quality legal services to clients doing business throughout the world.